CRISPR Therapeutics AG (CRSP) Insider Trading -- Recent Executive & Director Transactions
7 insiders reported 66 Form 4 transactions for CRISPR Therapeutics AG (CRSP) over the past 18 months (most recent 2026-10-08). Recent activity: KASINGER JAMES R. (General Counsel and Secretary) Buy 1,990 shares, KASINGER JAMES R. (General Counsel and Secretary) Sell 1,990 shares, KASINGER JAMES R. (General Counsel and Secretary) Buy 10,400 shares, KASINGER JAMES R. (General Counsel and Secretary) Sell 10,400 shares, Behbahani Ali (Director) Buy 60 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-08 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 1,990 | $27,104 |
| 2026-10-08 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 1,990 | $119,481 |
| 2026-09-24 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 10,400 | $141,648 |
| 2026-09-24 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 10,400 | $626,460 |
| 2026-09-21 | Behbahani Ali | Director | Buy | 60 | $0 |
| 2026-09-21 | Behbahani Ali | Director | Buy | 30,000 | $420,000 |
| 2026-09-21 | Behbahani Ali | Director | Buy | 15 | $0 |
| 2026-09-21 | Behbahani Ali | Director | Sell | 13,679 | $780,935 |
| 2026-08-11 | Prasad Raju | Chief Financial Officer | Sell | 750 | $0 |
| 2026-06-01 | Patel Naimish | Chief Medical Officer | Sell | 3,786 | $210,577 |
| 2026-06-01 | Patel Naimish | Chief Medical Officer | Buy | 10,000 | $0 |
| 2026-03-24 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 6,250 | $0 |
| 2026-03-24 | Prasad Raju | Chief Financial Officer | Buy | 6,250 | $0 |
| 2026-03-24 | Prasad Raju | Chief Financial Officer | Sell | 3,708 | $173,460 |
| 2026-03-24 | Kulkarni Samarth | Chief Executive Officer | Buy | 19,687 | $0 |
| 2026-03-24 | Kulkarni Samarth | Chief Executive Officer | Sell | 10,020 | $468,736 |
| 2026-03-24 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,182 | $148,854 |
| 2026-03-17 | Kulkarni Samarth | Chief Executive Officer | Buy | 20,625 | $0 |
| 2026-03-17 | KASINGER JAMES R. | General Counsel and Secretary | Buy | 6,875 | $0 |
| 2026-03-17 | KASINGER JAMES R. | General Counsel and Secretary | Sell | 3,450 | $166,497 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Buy | 10,000 | $0 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Buy | 6,875 | $0 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 5,848 | $282,224 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 4,021 | $194,053 |
| 2026-03-17 | Prasad Raju | Chief Financial Officer | Sell | 750 | $0 |
Source: SEC Form 4 filings · as of 2026-10-08